MRD Clinical Trials in Suzhou, Jiangsu
2 recruitingSuzhou, Jiangsu, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL
ALLMRD-positiveHematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD42 enrolled1 locationNCT05940961
Recruiting
Phase 4
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
MRDMultiple MyelomaHigh-Risk+1 more
The First Affiliated Hospital of Soochow University59 enrolled1 locationNCT06409702